ID

40405

Descripción

Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01038674

Link

https://clinicaltrials.gov/show/NCT01038674

Palabras clave

Versiones (1)
  1. 18/4/20 18/4/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

18 de abril de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Inflammation NCT01038674

Inglés

Eligibility Inflammation NCT01038674

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained before any trial-related activities
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
a diagnosis of rheumatoid arthritis made at least 3 months prior to screening
Descripción

Rheumatoid Arthritis Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0449238
active rheumatoid arthritis, characterised by a das28 equal or above 3.2
Descripción

Rheumatoid Arthritis DAS28

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C4481729
methotrexate treatment (stable dose, equal or below 25 mg/week) for at least 4 weeks prior to study start (subjects receiving stable doses of oral corticosteroids, and/or non-steroidal anti-inflammatory drugs and/or acetaminophen and/or opioids according to prescribed recommended doses can be included)
Descripción

Methotrexate Dose Stable | Adrenal Cortex Hormones Oral Dose Stable | Non-Steroidal Anti-Inflammatory Agents Dose Recommended | Acetaminophen Dose Recommended | Opioids Dose Recommended

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0178602
UMLS CUI [2,4]
C0205360
UMLS CUI [3,1]
C0003211
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0034866
UMLS CUI [4,1]
C0000970
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0034866
UMLS CUI [5,1]
C0242402
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0034866
male subjects and female subjects of non-child bearing potential
Descripción

Male infertility | Childbearing Potential Absent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021364
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
body mass index (bmi) less than 18.5 or above 35.0 kg/m2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
subjects with chronic inflammatory autoimmune disease other than rheumatoid arthritis
Descripción

Autoimmune Diseases inflammatory chronic | Exception Rheumatoid Arthritis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0333348
UMLS CUI [1,3]
C0205191
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003873
history of or current inflammatory joint disease other than rheumatoid arthritis
Descripción

Inflammatory joint disease | Exception Rheumatoid Arthritis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0683381
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003873
chronic or ongoing infectious disease requiring systemic anti-infectious treatment within 2 weeks prior to study start
Descripción

Chronic infectious disease | Communicable Diseases | Requirement Anti-infective therapy Systemic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151317
UMLS CUI [2]
C0009450
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C1141958
UMLS CUI [3,3]
C0205373
past or current malignancy (as judged by the investigator)
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
clinically significant cardiac or cardiovascular disease
Descripción

Heart Diseases | Cardiovascular Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0007222
positive for human immunodeficiency virus (hiv), hepatitis or tuberculosis
Descripción

HIV Seropositivity | Hepatitis | Tuberculosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0019158
UMLS CUI [3]
C0041296
blood donation or blood loss of more than 0.45l within 2 months prior to study start, or longer if required by local regulations
Descripción

Blood Donation Amount Timespan | Blood Loss Amount Timespan

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0872291
UMLS CUI [2,1]
C3163616
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0872291
breast-feeding women
Descripción

Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Inflammation NCT01038674

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
informed consent obtained before any trial-related activities
boolean
C0021430 (UMLS CUI [1])
Rheumatoid Arthritis Duration
Item
a diagnosis of rheumatoid arthritis made at least 3 months prior to screening
boolean
C0003873 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Rheumatoid Arthritis DAS28
Item
active rheumatoid arthritis, characterised by a das28 equal or above 3.2
boolean
C0003873 (UMLS CUI [1,1])
C4481729 (UMLS CUI [1,2])
Methotrexate Dose Stable | Adrenal Cortex Hormones Oral Dose Stable | Non-Steroidal Anti-Inflammatory Agents Dose Recommended | Acetaminophen Dose Recommended | Opioids Dose Recommended
Item
methotrexate treatment (stable dose, equal or below 25 mg/week) for at least 4 weeks prior to study start (subjects receiving stable doses of oral corticosteroids, and/or non-steroidal anti-inflammatory drugs and/or acetaminophen and/or opioids according to prescribed recommended doses can be included)
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
C0003211 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0034866 (UMLS CUI [3,3])
C0000970 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0034866 (UMLS CUI [4,3])
C0242402 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0034866 (UMLS CUI [5,3])
Male infertility | Childbearing Potential Absent
Item
male subjects and female subjects of non-child bearing potential
boolean
C0021364 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Body mass index
Item
body mass index (bmi) less than 18.5 or above 35.0 kg/m2
boolean
C1305855 (UMLS CUI [1])
Autoimmune Diseases inflammatory chronic | Exception Rheumatoid Arthritis
Item
subjects with chronic inflammatory autoimmune disease other than rheumatoid arthritis
boolean
C0004364 (UMLS CUI [1,1])
C0333348 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Inflammatory joint disease | Exception Rheumatoid Arthritis
Item
history of or current inflammatory joint disease other than rheumatoid arthritis
boolean
C0683381 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Chronic infectious disease | Communicable Diseases | Requirement Anti-infective therapy Systemic
Item
chronic or ongoing infectious disease requiring systemic anti-infectious treatment within 2 weeks prior to study start
boolean
C0151317 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
C1514873 (UMLS CUI [3,1])
C1141958 (UMLS CUI [3,2])
C0205373 (UMLS CUI [3,3])
Malignant Neoplasms
Item
past or current malignancy (as judged by the investigator)
boolean
C0006826 (UMLS CUI [1])
Heart Diseases | Cardiovascular Diseases
Item
clinically significant cardiac or cardiovascular disease
boolean
C0018799 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
HIV Seropositivity | Hepatitis | Tuberculosis
Item
positive for human immunodeficiency virus (hiv), hepatitis or tuberculosis
boolean
C0019699 (UMLS CUI [1])
C0019158 (UMLS CUI [2])
C0041296 (UMLS CUI [3])
Blood Donation Amount Timespan | Blood Loss Amount Timespan
Item
blood donation or blood loss of more than 0.45l within 2 months prior to study start, or longer if required by local regulations
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0872291 (UMLS CUI [1,3])
C3163616 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0872291 (UMLS CUI [2,3])
Breast Feeding
Item
breast-feeding women
boolean
C0006147 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial